The DOI matches its Crossref record; 124 of the 127 references it cites were found in a registry or an index.
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
Open accessAbstract
Used since ancient times especially for the local treatment of pulmonary diseases, lungs and airways are a versatile target route for the administration of both local and systemic drugs. Despite the existence of different platforms and devices for the pulmonary administration of drugs, only a few formulations are marketed, partly due to physiological and technological limitations. Respiratory infections represent a significant burden to health systems worldwide mainly due to intrahospital infections that more easily affect immune-compromised patients. Moreover, tuberculosis (TB) is an endemic infectious disease in many developing nations and it has resurged in the developed world associated with the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic. Currently, medicine faces the specter of antibiotic resistance. Besides the development of new anti-infectious drugs, the development of innovative and more efficient delivery systems for drugs that went off patent appears as a promising strategy pursued by the pharmaceutical industry to improve the therapeutic outcomes and to prolong the utilities of their intellectual property portfolio. In this context, nanotechnology-based drug delivery systems (nano-DDS) emerged as a promising approach to circumvent the limitations of conventional formulations and to treat drug resistance, opening the hypothesis for new developments in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the nanodrug delivery system reduces the adverse systemic side effects and frequency of drug administration, which eventually leads to better patient compliance.196,197”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 2,057
International Conference on Harmonisation
Guy, R. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,487
Labiris, N., & Dolovich, M. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,212
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 1,009
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-W. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 904
Formulation strategy and use of excipients in pulmonary drug delivery
Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 816
Amphotericin B: side effects and toxicity
Laniado-Laborín, R., & Cabrales-Vargas, M. N. (2009) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.06.003 · Cited by 739
Influence of particle size on regional lung deposition – What evidence is there?
Carvalho, T. C., Peters, J. I., & Williams III, R. O. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.040 · Cited by 614
Cited by
Sorted by citations
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,279
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 917
Self-citationNanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez‐Gascón, A., Almeida, A. J., & Véronique Préat, A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 790
Antibiotic‐Free Antibacterial Strategies Enabled by Nanomaterials: Progress and Perspectives
Wang, Y., Yang, Y., Shi, Y., Song, H., & Yu, C. (2019) · Advanced Materials · doi:10.1002/adma.201904106 · Cited by 703
Sosnik, A., & Seremeta, K. P. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.05.003 · Cited by 679
Self-citationTargeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Polymeric Nanostructures for Imaging and Therapy
Elsabahy, M., Heo, G. S., Lim, S., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 515
Sosnik, A., das Neves, J., & Sarmento, B. F. C. C. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.07.010 · Cited by 495
Self-citationCurrent applications of nanoparticles in infectious diseases
Gómez, H. Z., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 440
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 378
Yousefi, M., Dadashpour, M., Hejazi, M., Hasanzadeh, M., Behnam, B., de la Guárdia, M., Shadjou, N., & Mokhtarzadeh, A. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.12.125 · Cited by 267
Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics
Mubeen, B., Ansar, A. N., Rasool, R., Ullah, I., Imam, S. S., Alshehri, S., Ghoneim, M. M., Alzarea, S. I., Nadeem, M. S., & Kazmi, I. A. (2021) · Antibiotics · doi:10.3390/antibiotics10121473 · Cited by 257
Inhaled formulations and pulmonary drug delivery systems for respiratory infections
Zhou, Q. T., Leung, S. S. Y., Tang, P., Parumasivam, T., Loh, Z. H., & Chan, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.022 · Cited by 252
Haripriyaa, M., & Suthindhiran, K. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00569-y · Cited by 196
Pulmonary drug delivery systems for tuberculosis treatment
Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185
Mesoporous silica nanoparticles for pulmonary drug delivery
García‐Fernández, A., Sancenón, F., & Martínez‐Máñez, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113953 · Cited by 183
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
Guo, Y., Bera, H., Shi, C., Zhang, L., Cun, D., & Yang, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.015 · Cited by 172
Pulmonary drug delivery by powder aerosols
Yang, M., Chan, J. G. Y., & Chan, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.055 · Cited by 170
Polymeric micelles in mucosal drug delivery: challenges towards clinical translation
Sosnik, A., & Menaker Raskin, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.003 · Cited by 154
Self-citationAli, S. S., Morsy, R., El-Zawawy, N. A., Fareed, M. F., & Bedaiwy, M. Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s141201 · Cited by 149
Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
Park, Y.-M., Lee, S. J., Kim, Y. S., Lee, M. H., Cha, G. S., Jung, I. D., Kang, T. H., & Han, H. D. (2013) · Immune Network · doi:10.4110/in.2013.13.5.177 · Cited by 135
Chang, X., Zhou, S., Yan, Z., Zhang, Q., Liu, J., Wang, Y., Guan, X., Wu, Q., & Liu, R. (2025) · Phytotherapy Research · doi:10.1002/ptr.70008 · Cited by 138
Mehta, P. P., Ghoshal, D., Pawar, A., Kadam, S. S., & Dhapte-Pawar, V. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101509 · Cited by 128
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123
Self-citationMedical applications and prospects of polylactic acid materials
Yang, Z., Yin, G., Sun, S., & Xu, P. (2024) · iScience · doi:10.1016/j.isci.2024.111512 · Cited by 125
Respirable nanocarriers as a promising strategy for antitubercular drug delivery
Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.038 · Cited by 119
Naskar, A., & Kim, K.-S. (2019) · Microorganisms · doi:10.3390/microorganisms7090356 · Cited by 121
Darbasizadeh, B., Fatahi, Y., Feyzi-barnaji, B., Arabi, M., Motasadizadeh, H., Farhadnejad, H., Moraffah, F., & Rabiee, N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.060 · Cited by 112
Huang, Z., Kłodzińska, S. N., Wan, F., & Nielsen, H. M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00954-1 · Cited by 113
Chen, J., Shi, X., Zhu, Y., Chen, Y., Gao, M., Gao, H., Liu, L., Wang, L., Mao, C., & Wang, Y. (2019) · Theranostics · doi:10.7150/thno.38388 · Cited by 110
Du, Y., Yu, M., Ge, J., Ma, P. X., Chen, X., & Lei, B. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501712 · Cited by 95
Adeniji, O. O., Nontongana, N., Okoh, J. C., & Okoh, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315038 · Cited by 93
Al‐Bakri, A. G., & Mahmoud, N. N. (2019) · Molecules · doi:10.3390/molecules24142661 · Cited by 93
Wang, H., Lu, Q., Zhang, X., Guan, J., & Mao, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.061 · Cited by 90
Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy
Moreno-Sastre, M., Pastor, M., Salomon, C. J., Esquisabel, A., & Pedraz, J. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv192 · Cited by 84
Velkov, T., Rahim, N. A., Zhou, Q. T., Chan, H., & Li, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.004 · Cited by 84
Moreno-Sastre, M., Pastor, M., Esquisabel, A., Sans, E., Viñas, M., Fleischer, A., Palomino, E., Bachiller, D., & Pedraz, J. L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.028 · Cited by 84
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 81
Muralidharan, P., Mallory, E. K., Malapit, M., Hayes, D., & Mansour, H. M. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6020333 · Cited by 76
Araújo, V. H. S., Filippo, L. D. D., Duarte, J. L., Spósito, L., de Camargo, B. A. F., da Silva, P. B., & Chorilli, M. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843399 · Cited by 73
das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 74
Self-citationCyclic Peptide–Selenium Nanoparticles as Drug Transporters
Shirazi, A. N., Tiwari, R. K., Oh, D., Sullivan, B., Kumar, A., Beni, Y. A., & Parang, K. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500364a · Cited by 71
Nanoparticles: Antimicrobial Applications and Its Prospects
Varier, K. M., Gudeppu, M., Chinnasamy, A., Sumathi, T., Balasubramanian, J., Li, Y., & Gajendran, B. (2019) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-04477-0_12 · Cited by 69
Machelart, A., Salzano, G., Li, X., Demars, A. M., Debrie, A., Menéndez-Miranda, M., Pancani, E., Jouny, S., Hoffmann, E., Deboosère, N., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07902 · Cited by 69
Pastor, M., Moreno-Sastre, M., Esquisabel, A., Sans, E., Viñas, M., Bachiller, D., Asensio, V. J., del Pozo, Á., Gaínza, E., & Pedraz, J. L. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.048 · Cited by 68
How can nanoparticles contribute to antituberculosis therapy?
Costa-Gouveia, J., Aínsa, J. A., Brodin, P. M., & Lucía, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.011 · Cited by 68
Manca, M. L., Peris, J., Melis, V., Valenti, D., Cardia, M. C., Lattuada, D., Escribano‐Ferrer, E., Fadda, A. M., & Manconi, M. (2015) · RSC Advances · doi:10.1039/c5ra24032h · Cited by 67
Safety Assessment of Nanomaterials for Antimicrobial Applications
Ali, A. S., Ovais, M., Cui, X., Rui, Y., & Chen, C. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00519 · Cited by 65
Human immunity in vitro — Solving immunogenicity and more
Giese, C., & Marx, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.011 · Cited by 65
Metal-based nanoparticles for combating antibiotic resistance
Altun, E., Aydoğdu, M. O., Chung, E., Ren, G., Homer‐Vanniasinkam, S., & Edirisinghe, M. J. (2021) · Applied Physics Reviews · doi:10.1063/5.0060299 · Cited by 64
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs
Melis, V., Manca, M. L., Bullita, E., Tamburini, E., Castangia, I., Cardia, M. C., Valenti, D., Fadda, A. M., Peris, J., & Manconi, M. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.044 · Cited by 60
Ghavam, M., Manconi, M., Manca, M. L., & Bacchetta, G. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113513 · Cited by 60
Emerging aerosol drug delivery strategies: From bench to clinic
Rubin, B. K., & Williams, R. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.008 · Cited by 57
Nanomedicines in the future of pediatric therapy.
Sosnik, A., & Carcaboso, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.004 · Cited by 54
Self-citationSabuj, M. Z. R., & Islam, N. (2021) · Nanoscale Advances · doi:10.1039/d1na00205h · Cited by 56
Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin
Andrade, F., das Neves, J., Gener, P., Schwartz, S., Ferreira, D., Oliva, M., & Sarmento, B. F. C. C. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.006 · Cited by 55
Self-citationDelivery of genome-editing biomacromolecules for treatment of lung genetic disorders
Wan, T. Y., & Yuan, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.002 · Cited by 55
Song, X., Liu, P., Liu, X., Wang, Y., Wei, H., Zhang, J., Yu, L., Yan, X., & He, Z. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112318 · Cited by 59
A mechanistic perspective on targeting bacterial drug resistance with nanoparticles
Khorsandi, K., Keyvani‐Ghamsari, S., Shahidi, F. K., Hosseinzadeh, R., & Kanwal, S. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1895818 · Cited by 56
Zupančič, Š., Potrč, T., Baumgartner, S., Kocbek, P., & Kristl, J. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.030 · Cited by 52
Antibiotic resistance and nanotechnology: A narrative review
Zhu, X., Tang, Q., Zhou, X., & Momeni, M. R. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106741 · Cited by 52
Li, J., Zhang, K., Wu, D., Ren, L., Chu, X., Qin, C., Han, X., Hang, T., Xu, Y., Yang, L., et al. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.09.002 · Cited by 48
Dawood, A. S., Algharib, S. A., Zhao, G., Zhu, T., Qi, M., Delai, K., Hao, Z., Marawan, M. A., Shirani, I., & Guo, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.855731 · Cited by 48
Kiełbik, P., Kaszewski, J., Rosowska, J., Wolska, E., Witkowski, B. S., Gralak, M. A., Gajewski, Z., Godlewski, M., & Godlewski, M. M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.002 · Cited by 48
Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
Balasubramanian, V., Liu, Z., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700432 · Cited by 48
Igarashi, M., Ishizaki, Y., & Takahashi, Y. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.126 · Cited by 46
Buyana, B., Aderibigbe, B. A., Ndinteh, D. T., Fonkui, T. Y., & Kumar, P. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101960 · Cited by 47
Solubility and Dissolution Enhancement of Tadalafil Using Self-Nanoemulsifying Drug Delivery System
El‐Badry, M., Haq, N., Fetih, G. N., & Shakeel, F. (2014) · Journal of Oleo Science · doi:10.5650/jos.ess13236 · Cited by 45
Xu, C., Tian, H., Wang, P., Wang, Y., & Chen, X. (2016) · Biomaterials Science · doi:10.1039/c6bm00601a · Cited by 45
Ibarra-Sánchez, L. Á., Gámez-Méndez, A. M., Martínez-Ruiz, M., Nájera-Martínez, E. F., Morales-Flores, B., Melchor-Martínez, E. M., Sosa‐Hernández, J. E., Parra‐Saldívar, R., & Iqbal, H. M. N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103219 · Cited by 45
Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections
Xu, K., Liang, Z. C., Ding, X., Hu, H., Liu, S., Nurmik, M., Bi, S., Hu, F.-S., Ji, Z., Ren, J., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700509 · Cited by 44
Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa
Yan, X., & Sha, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102457 · Cited by 43
Valle, I. V., Machado, M. E., Araújo, C. D. C. B., Cunha‐Júnior, E. F., Pacheco, J. D. S., Torres-Santos, E. C., da Silva, L. C. R. P., Cabral, L. M., do Carmo, F. A., & Sathler, P. C. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab373e · Cited by 43
Production of Drug-Loaded Polymeric Nanoparticles by Electrospraying Technology
Sosnik, A. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1887 · Cited by 42
Self-citationPulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment
Li, J., Zheng, H., & Leung, S. S. Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03379-8 · Cited by 41
Rafael, D. F. D. S., Martínez-Trucharte, F., Andrade, F., Seras‐Franzoso, J., García‐Aranda, N., Gener, P., Sayós, J., Arango, D., Abasolo, I., & Schwartz, S. (2017) · Chemical Engineering Journal · doi:10.1016/j.cej.2017.12.114 · Cited by 40
Self-citationRafael, D. F. D. S., Gener, P., Andrade, F., Seras‐Franzoso, J., Montero, S., Fernández, Y., Hidalgo, M. M., Arango, D., Sayós, J., Florindo, H. F., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461276 · Cited by 41
Self-citationvan der Weide, H., Cossío, U., Gracia, R., Welscher, Y. M. T., ten Kate, M. T., van der Meijden, A., Marradi, M., Ritsema, J. A. S., Jongh, D. M. C. V.-D., Storm, G., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-20 · Cited by 40
A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery
Pasero, L., Susa, F., Limongi, T., & Pisano, R. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124248 · Cited by 39
Farhangi, M. A., Mahboubi, A., Kobarfard, F., Vatanara, A., & Mortazavi, S. A. (2018) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2018.1545237 · Cited by 39
Nanoparticle-Based Devices in the Control of Antibiotic Resistant Bacteria
Gómez-Núñez, M. F., Castillo-López, M., Sevilla-Castillo, F., Roque-Reyes, O. J., Romero-Lechuga, F., Medina-Santos, D., Daniel, R., & Peón, A. N. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.563821 · Cited by 41
Long-acting vaccine delivery systems
Walvekar, P., Kumar, P., & Choonara, Y. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114897 · Cited by 39
Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines
Beg, S., Kawish, S. M., Panda, S. K., Tarique, M., Malik, A., Afaq, S., AlSamghan, A. S., Iqbal, J., Alam, K., & Rahman, M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.005 · Cited by 38
Andrade, F., Fonte, P., Oliva, M., Videira, M., Ferreira, D., & Sarmento, B. F. C. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.050 · Cited by 38
Self-citationNanopolymersomes as potential carriers for rifampicin pulmonary delivery
Moretton, M. A., Cagel, M., Bernabeu, E., González, L., & Chiappetta, D. A. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.049 · Cited by 36
A review of available techniques for determination of nano-antimicrobials activity
Hoseinzadeh, E., Makhdoumi, P., Taha, P., Hossini, H., Pirsaheb, M., Rastegar, S. O., & Stelling, J. M. (2016) · Toxin Reviews · doi:10.1080/15569543.2016.1237527 · Cited by 38
Mhule, D., Kalhapure, R. S., Jadhav, M., Omolo, C. A., Rambharose, S., Mocktar, C., Singh, S. D., Waddad, A. Y., Ndesendo, V. M. K., & Govender, T. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.025 · Cited by 36
Monodispersed metal-based dendrimeric nanoclusters for potentiation of anti-tuberculosis action
Rodrigues, B., & Shende, P. K. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.112731 · Cited by 36
Sarkar, K., Kumar, M., Jha, A., Bharti, K., Das, M., & Mishra, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102850 · Cited by 36
Nainwal, N. (2022) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2022.102170 · Cited by 36
Shastri, D., Raj, V., & Lee, S.-K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102379 · Cited by 34
Silva, M., Silva, A. S., Fernández‐Lodeiro, J., Casimiro, T., Lodeiro, C., & Aguiar‐Ricardo, A. (2017) · Materials · doi:10.3390/ma10010074 · Cited by 34
Patel, A., Redinger, N., Richter, A., Woods, A., Neumann, P., Keegan, G. M., Childerhouse, N., Imming, P., Schaible, U. E., Forbes, B., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.022 · Cited by 34
Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects
Gulati, N., Chellappan, D. K., MacLoughlin, R. J., Dua, K., & Dureja, H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119969 · Cited by 34
Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies
Sued, O. G., Figueroa, M. I., & Cahn, P. E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.016 · Cited by 32
The challenges and applications of nanotechnology against bacterial resistance
Lei, Z., & Karim, A. (2020) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12936 · Cited by 32
Recent Advances in Nanotechnology for the Management of Klebsiella pneumoniae–Related Infections
Barani, M., Fathizadeh, H., Arkaban, H., Kalantar-Neyestanaki, D., Akbarizadeh, M. R., Jalil, A. T., & Akhavan‐Sigari, R. (2022) · Biosensors · doi:10.3390/bios12121155 · Cited by 32
Li, J., Hao, X., Wang, C., Liu, H., Liu, L., He, X., & Sun, C. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040546 · Cited by 31
Metadata
- Authors
- Andrade, F., Rafael, D., Videira, M., Ferreira, D., Sosnik, A., & Sarmento, B.
- Affiliations
- Universidade do Porto (PT)
- University of Lisbon (PT)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- Andrade, Fernanda
- Sarmento, Bruno
- ORCID
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 65
- Issue
- 13-14
- Pages
- 1816-1827
- ISSN
- 0169-409X (ISSN-L)
- PMC
- PMC7103277
- OpenAlex
- W2010047058
- Cited by
- 245
- References
- 127
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 23 · 2023: 22 · 2022: 21 · 2021: 29 · 2020: 23 · 2019: 26 · 2018: 11 · 2017: 17 · 2016: 10 · 2015: 19 · 2014: 16 · 2013: 1
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia (FCT) (SFRH/BD/73062/2010)
- FCT (Portugal)/Ministry of Science, Technology and Innovation (MINCyT, Argentina)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- pulmonary drug delivery, respiratory infections, tuberculosis, HIV/AIDS, antibiotic resistance, immunocompromised patients
- MeSH terms
- Administration, Inhalation, Animals, Anti-Infective Agents, Chemistry, Pharmaceutical, Drug Carriers, Drug Resistance, Microbial, Equipment Design, Humans, Nebulizers and Vaporizers, Respiratory Tract Infections, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review